Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS)
CNY 9.71
(-1.32%)
CNY 9.71
(-1.32%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 328.28 Million CNY | 8.2% |
| 2022 | 303.39 Million CNY | 18.18% |
| 2021 | 256.72 Million CNY | 22.38% |
| 2020 | 209.77 Million CNY | 1.58% |
| 2019 | 206.51 Million CNY | 7.18% |
| 2018 | 192.67 Million CNY | 11.76% |
| 2017 | 172.4 Million CNY | 64.66% |
| 2016 | 104.69 Million CNY | 21.95% |
| 2015 | 85.85 Million CNY | -0.82% |
| 2014 | 86.56 Million CNY | 12.93% |
| 2013 | 76.65 Million CNY | 2.42% |
| 2012 | 74.84 Million CNY | 88.57% |
| 2011 | 39.69 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 384.09 Million CNY | 2.46% |
| 2024 Q2 | 374.87 Million CNY | 2.77% |
| 2024 Q1 | 364.76 Million CNY | 11.11% |
| 2023 Q3 | 372.02 Million CNY | 1.37% |
| 2023 Q4 | 328.28 Million CNY | -11.76% |
| 2023 Q1 | 346.84 Million CNY | 14.32% |
| 2023 Q2 | 367.01 Million CNY | 5.81% |
| 2023 FY | 328.28 Million CNY | 8.2% |
| 2022 Q4 | 303.39 Million CNY | 5.08% |
| 2022 Q3 | 288.72 Million CNY | -3.42% |
| 2022 Q2 | 298.94 Million CNY | 7.57% |
| 2022 Q1 | 277.9 Million CNY | 8.25% |
| 2022 FY | 303.39 Million CNY | 18.18% |
| 2021 Q4 | 256.72 Million CNY | 0.34% |
| 2021 Q2 | 249.27 Million CNY | 16.03% |
| 2021 Q3 | 255.85 Million CNY | 2.64% |
| 2021 FY | 256.72 Million CNY | 22.38% |
| 2021 Q1 | 214.84 Million CNY | 2.42% |
| 2020 Q1 | 213.2 Million CNY | 3.24% |
| 2020 Q2 | 209.2 Million CNY | -1.88% |
| 2020 Q3 | 198.04 Million CNY | -5.34% |
| 2020 Q4 | 209.77 Million CNY | 5.93% |
| 2020 FY | 209.77 Million CNY | 1.58% |
| 2019 Q3 | 202.06 Million CNY | 0.04% |
| 2019 Q2 | 201.98 Million CNY | 12.45% |
| 2019 Q4 | 206.51 Million CNY | 2.2% |
| 2019 FY | 206.51 Million CNY | 7.18% |
| 2019 Q1 | 179.62 Million CNY | -6.77% |
| 2018 Q1 | 188.37 Million CNY | 9.27% |
| 2018 FY | 192.67 Million CNY | 11.76% |
| 2018 Q4 | 192.67 Million CNY | 5.76% |
| 2018 Q3 | 182.18 Million CNY | -2.5% |
| 2018 Q2 | 186.84 Million CNY | -0.81% |
| 2017 Q4 | 172.4 Million CNY | 12.18% |
| 2017 Q1 | 120.49 Million CNY | 15.09% |
| 2017 Q3 | 153.68 Million CNY | 26.47% |
| 2017 FY | 172.4 Million CNY | 64.66% |
| 2017 Q2 | 121.52 Million CNY | 0.85% |
| 2016 Q1 | 96.08 Million CNY | 11.91% |
| 2016 FY | 104.69 Million CNY | 21.95% |
| 2016 Q3 | 116.35 Million CNY | 5.87% |
| 2016 Q2 | 109.9 Million CNY | 14.38% |
| 2016 Q4 | 104.69 Million CNY | -10.02% |
| 2015 Q2 | 77.84 Million CNY | -5.45% |
| 2015 Q1 | 82.33 Million CNY | -4.89% |
| 2015 Q4 | 85.85 Million CNY | 1.18% |
| 2015 FY | 85.85 Million CNY | -0.82% |
| 2015 Q3 | 84.85 Million CNY | 9.0% |
| 2014 Q2 | 99.26 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q3 | 95.56 Million CNY | -3.72% |
| 2014 Q4 | 86.56 Million CNY | -9.42% |
| 2014 FY | 86.56 Million CNY | 12.93% |
| 2013 FY | 76.65 Million CNY | 2.42% |
| 2013 Q4 | 76.65 Million CNY | 0.0% |
| 2012 FY | 74.84 Million CNY | 88.57% |
| 2011 FY | 39.69 Million CNY | 0.0% |